Bisamidine Derivatives as Candidates for Tegumentary Leishmaniasis Therapy: Phenotypic Screening in Infection of Macrophages and Mechanistic Insights with Dual RNA-seq
Open Access
- 27 March 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (13) , 20270-20284
Abstract
Leishmania braziliensis is the primary causative agent of American tegumentary leishmaniasis (ATL), a critical parasitic tropical neglected disease. The chemotherapeutic arsenal has limited efficacy and significant toxic effects that lead to an urgent need to develop new medicines. Using the “drug repurposing” approach, histone-modifying enzyme inhibitors have been the subject of developing new drugs against neglected parasitic diseases. In this work, furamidine, a known diphenyl furan inhibitor of human Protein Arginine Methyltransferase (PRMT), along with a library of 31 developed analogues, was tested for leishmanicidal activity against L. braziliensis in the in vitro infection of macrophage assay. The most active and selective leishmanicidal analogue, BSF2 (EC50 of 0.64 μM (95% CI: 0.56–0.72), SI of 17.36), was further investigated by dual RNA-seq at 0.16 μM BSF2. The dual-transcriptome detected only 10 genes with significant differential expression (FDR ≤10%) in L. braziliensis related to ubiquitination, chromatin remodeling, and peroxisomal membrane transport pathways, following BSF2 treatment of infected macrophages. In addition, BSF2 had a significant effect (FDR ≤5%) on the expression of 577 genes in the infected macrophages, including the downregulation of TNF, IL-17, NF-κB, and Toll-like receptor pathways. This work opens new venues for developing new chemotherapy for leishmaniasis based on BSF2 or derivatives and highlights the dual transcriptome as a valuable phenotypic assay tool to investigate host–parasite interactions for antileishmanial drug discovery.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (306140/2021-7)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (313781/2025-7)
- Fundação Butantan
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
- Seventh Framework Programme (602080)
This publication has 68 references indexed in Scilit:
- Leishmaniasis: where are we and where are we heading?Parasitology Research, 2021
- Susceptibility to paromomycin in clinical isolates and reference strains of Leishmania species responsible for tegumentary leishmaniasis in BrazilActa Tropica, 2021
- Novel findings on the role of ficolins and colectins in the innate response against Leishmania braziliensisActa Tropica, 2020
- Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patientsActa Tropica, 2018
- Mechanisms of Immune Evasion in Leishmaniasis2013
- Epigenetic mechanisms in mammalsCellular and Molecular Life Sciences, 2008
- Efficacy of the diamidine DB75 and its prodrug DB289, against murine models of human African trypanosomiasisActa Tropica, 2008
- A novel form of NF‐κB is induced by Leishmania infection: Involvement in macrophage gene expressionEuropean Journal of Immunology, 2008
- Activity of “reversed” diamidines against Trypanosoma cruzi “in vitro”Biochemical Pharmacology, 2007
- Leishmania (Viannia) braziliensis is the prevalente species infecting patients with tegumentary leishmaniasis from Mato Grosso State, BrazilActa Tropica, 2006